frexalimabfrexalimab1200mgfrexalimab300mgpwRMSrelapsing multiple sclerosisNCT04879628COVID-19
…628) in participants with relapsing multiple sclerosis (pwRMS), frexalimab was well-tolerated and efficacious, with 1200-mg intravenous (I…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: frexalimab300mg ×
frexalimab300mg
This drug is selected. Its supporting articles are shown below.